nominally significantP < 0.05
First, in step A, we screened for the presence of nominally significant ( P < 0.05) cumulative effects of associated methylation sites in whole blood, to determine which factors and variables to include in the full-scale analysis, thereby minimizing false positive findings in the downstream analysis.